CORC  > 山东大学
Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy
Wang, Yue-shen; Tian, Jing; Han, Yong; Han, Shu-mei; Shi, Sheng-bin
刊名ONCOLOGY RESEARCH
2016
卷号24期号:2页码:129-135
关键词Advanced esophageal cancer Second-line treatment Gemcitabine plus vinorelbine Platinum-based chemotherapy miRNA-214 Progression-free survival
DOI10.3727/096504016X14618564639213
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4695197
专题山东大学
作者单位1.Jilin Peoples Hosp, Dept Oncol, Jilin, Jilin, Peoples R China.
2.Shandong Univ
推荐引用方式
GB/T 7714
Wang, Yue-shen,Tian, Jing,Han, Yong,et al. Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy[J]. ONCOLOGY RESEARCH,2016,24(2):129-135.
APA Wang, Yue-shen,Tian, Jing,Han, Yong,Han, Shu-mei,&Shi, Sheng-bin.(2016).Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy.ONCOLOGY RESEARCH,24(2),129-135.
MLA Wang, Yue-shen,et al."Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy".ONCOLOGY RESEARCH 24.2(2016):129-135.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace